Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution
<i>S</i>-CE-123, a novel dopamine transporter inhibitor, has emerged as a potential candidate for cognitive enhancement. The objective of this study was to compare the tissue distribution profiles, with a specific focus on central nervous system distribution and metabolism, of <i>S...
Main Authors: | Iva Spreitzer, Josefin Keife, Tobias Strasser, Predrag Kalaba, Jana Lubec, Winfried Neuhaus, Gert Lubec, Thierry Langer, Judith Wackerlig, Irena Loryan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/23/16956 |
Similar Items
-
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System
by: Claudia Sagheddu, et al.
Published: (2020-05-01) -
Novel Dopamine Transporter Inhibitor, CE-123, Ameliorates Spatial Memory Deficits Induced by Maternal Separation in Adolescent Rats: Impact of Sex
by: Pawel Grochecki, et al.
Published: (2022-09-01) -
Use of Modafinil in Psychiatric Disorders
by: Mehmet Hanifi Kokacya, et al.
Published: (2016-03-01) -
Social Interaction in Adolescent Rats with Neonatal Ethanol Exposure: Impact of Sex and CE-123, a Selective Dopamine Reuptake Inhibitor
by: Justyna Socha, et al.
Published: (2024-01-01) -
Cocrystals of Modafinil-Nicotinic Acid: A Novel Cocrystal for Enhanced Bioavailability
by: Tanmoy Ghosh, et al.
Published: (2021-01-01)